Cambridge, Massachusetts, an educational and cultural hub, is home to a vibrant biotech startup scene. This city not only hosts the world’s top universities such as MIT and Harvard, but also attracts educational, scientific, and entrepreneurial talent from around the globe. As part of our focus on startups across the United States, we will be spotlighting companies who were established in 2020 and are trailblazing within the Biotechnology sphere. Here, we bring you a list of remarkable startups that are bringing innovative solutions to health care and therapeutics.
NextPoint Therapeutics was founded by Gordon Freeman and Xingxing Zang. This startup is working on creating immunotherapies to expand benefits to cancer patients. By modulating both adaptive and innate immune systems, they aim to locate and eradicate cancer cells. You can find more information on their LinkedIn page.
Rosana Kapeller helms ROME Therapeutics, a company that seeks to develop novel therapies for cancer and autoimmune diseases. They’re doing this by utilizing the potential of the ‘repeatome’— vast stretches of uncharted genetic material within DNA. Check them out on their LinkedIn page for updates.
Founded by Dorothee Kern, Eva Nogales, Johannes Walter, and Timur Yusufzai, MOMA Therapeutics is pioneering the discovery of precision medicines targeting molecular machines underlying human disease. Follow them on Twitter at @moma_tx and check their LinkedIn for more information.
Under the leadership of Aleks Radovic-Moreno, David Rawlings, David Steinberg, and Lea Hachigian, Be Biopharma is developing a unique class of B cells as medicines. Be Biopharma is a must-watch, and you can follow their progress on their @bebiopharma handle or their LinkedIn page.
Vigil Neuroscience is a startup focusing on advancing a monoclonal antibody TREM2 agonist through Phase 1 studies and increasing the body of data supporting microglia biology as an important therapeutic pathway. Follow them on Twitter at @VigilNeuro or connect on their LinkedIn.
Focused on pioneering an entirely new class of genomic medicines, Theonys is a startup dedicated to advancing precision translational reprogramming as an innovative treatment approach for complex multigenic diseases like cancer. Reach out to them on their Twitter handle @Theonys_is_tRNA, or find more information on their LinkedIn page.
Clade Therapeutics, founded by Chad Cowan, Jim Glasheen, and Leandro Vetcher, is working on discovering and delivering scalable, off-the-shelf, next-generation stem-cell-based medicines. To stay updated, check out their LinkedIn.
Faze Medicines, founded by J. Paul Taylor, Mike Rosen, Ron Vale, and Roy Parker, focuses on using screening and proteomics techniques to define condensate interaction networks. You can keep up with their latest activities through their @fazemedicines Twitter handle or their LinkedIn page.
Totus Medicines, founded by Neil Dhawan, is revolutionizing the field by creating life-changing therapies to treat previously untreatable diseases across the entire human genome. You can follow them on Twitter at @totustx or connect with them on their LinkedIn.
Transition Bio, helmed by David Weitz, Peter St George-Hyslop, Sarah Teichmann, and Tuomas Knowles, is advancing condensate technology for drug discovery and diagnostics. They focus on the discovery, analysis, and modulation of biological condensates for drug development. Stay tuned to their LinkedIn page for more updates.
Founded by Branden S. Moriarity and Kevin Pojasek, Catamaran Bio specializes in allogeneic immune cell therapies, offering cell therapy products for patients with unmet medical needs. For more insights, stay connected with them via their LinkedIn page.
Innovation is flourishing in the biotechnology industry, and these startups are some of the important players ushering these advancements. The city of Cambridge, with its conducive startup ecosystem, has truly become a significant base for biotech startups shaping the future of healthcare and therapeutics.